Phase I and pharmacodynamic study of vorinostat combined with capecitabine and cisplatin as first-line chemotherapy in advanced gastric cancer

By Yoo Changhoon   Ryu Min-Hee   Na Young-Soon   Ryoo Baek-Yeol   Lee Chae-Won   Maeng Jeheon   Kim Se-Yeon   Koo Dong   Park Inkeun   Kang Yoon-Koo  

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 271-278

Springer Publishing Company

Access to resources Recommend Favorite

Phase I study of sunitinib plus S-1 and cisplatin in Japanese patients with advanced or metastatic gastric cancer

By Boku Narikazu   Muro Kei   Machida Nozomu   Hashigaki Satoshi   Kimura Nobuyuki   Suzuki Mie   Lechuga Mariajose   Miyata Yoshinori  

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 261-270

Springer Publishing Company

Access to resources Recommend Favorite

Capecitabine in advanced gastric cancer

By Okines Alicia   Chau Ian   Cunningham David  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 16, 2007-11 ,pp. : 2851-2861

Informa Healthcare

Access to resources Recommend Favorite

Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer

By Strickler John   McCall Shannon   Nixon Andrew   Brady John   Pang Herbert   Rushing Christel   Cohn Allen   Starodub Alexander   Arrowood Christy   Haley Sherri   Meadows Kellen   Morse Michael   Uronis Hope   Blobe Gerard   Hsu S.   Zafar S.   Hurwitz Herbert  

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 330-339

Springer Publishing Company

Access to resources Recommend Favorite

Capecitabine: In Advanced Gastric or Oesophagogastric Cancer

By Dhillon Sohita   Scott Lesley J.  

Drugs, Vol. 67, Iss. 4, 2007-01 ,pp. : 601-610

Adis International

Access to resources Recommend Favorite